文献速递临床试验与 GCP真实世界研究与卫生经济

自主导向与临床医生实施认知行为疗法治疗慢性疼痛的随机临床试验

Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01

该随机开放标签实用性优效试验纳入764例慢性肌肉骨骼疼痛患者,比较自主导向CBT-CP与临床医生实施的CBT-CP。所有次要结局也均更优,且治疗完成率更高。

要点

  • 自主导向CBT-CP在4个月时疼痛干扰改善优于临床医生实施CBT-CP。
  • 优势维持至6个月和12个月,所有次要结局在4个月时均更优。
  • 自主导向组完成预期治疗次数更多,可能提高CBT-CP的可及性。

核心结论

  • 自主导向CBT-CP在4个月时疼痛干扰改善优于临床医生实施CBT-CP,并维持至12个月。
  • 自主导向CBT-CP组完成预期治疗次数多于临床医生实施组。

研究设计与样本

  • 随机、开放标签、实用性优效试验,纳入764例慢性肌肉骨骼疼痛患者。
  • 来自美国9个退伍军人健康管理局医疗系统,2019年12月20日至2024年2月20日入组。
  • 按1:1分配至自主导向CBT-CP组(n=384)或临床医生实施CBT-CP组(n=380)。

主要发现

  • 自主导向CBT-CP在6个月和12个月维持对疼痛干扰的优效性。
  • 583例(76%)完成4个月评估,523例(68%)完成12个月评估。

关键数值与推荐

  • 主要结局为4个月时7项简明疼痛量表干扰子量表(BPI-I)评分,范围0-10,最小临床重要差异为1。
  • 自主导向CBT-CP包括11周治疗,每周由教练提供个性化录音反馈。
  • 临床医生实施CBT-CP包括4至11次每周会话,在常规实践条件下提供。

临床怎么用

  • 可扩展、方便的自主导向CBT可能作为临床医生实施CBT的有效替代,提高CBT-CP uptake。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cognitive behavioral therapy for chronic pain (CBT-CP) is a first-line nonpharmacological treatment, but uptake remains low due to multiple access barriers. OBJECTIVE: To assess the effectiveness of self-directed CBT-CP with asynchronous, personalized feedback relative to clinician-delivered CBT-CP under usual clinical practice conditions. DESIGN, SETTING, AND PARTICIPANTS: This randomized, open-label pragmatic superiority trial enrolled 764 patients with chronic musculoskeletal pain from 9 US Veterans Health Administration (VHA) health care systems from December 20, 2019, to February 20, 2024; follow-up was completed in February 2025. INTERVENTIONS: Participants were allocated 1:1 to self-directed CBT-CP (n = 384) or clinician-delivered CBT-CP (n = 380). The self-directed group included 11 weeks of treatment with weekly personalized audio-recorded feedback provided by coaches. Feedback was based on participants' daily reports of pain coping skill practice, physical activity, and pain-relevant ratings collected by the interactive voice response system. Clinician-delivered CBT-CP included 4 to 11 weekly sessions provided under usual practice conditions. MAIN OUTCOMES AND MEASURES: The primary outcome was patient-reported pain interference measured by the 7-item Brief Pain Inventory-Interference (BPI-I) subscale at 4 months (score range, 0-10; higher scores indicate worse function; minimum clinically important difference, 1). Secondary outcomes included BPI-I at 6 and 12 months; pain intensity, pain impact, catastrophizing, self-efficacy, sleep, global impression of change, depressive symptoms (all at 4 months); and treatment dose. RESULTS: Of the 764 randomized participants (mean age, 52.8 [SD, 12.3] years; 299 women [39.1%]; 289 Black [39.1%]; 399 White [54.0%]; and 107 Hispanic ethnicity [14.0%] and 186 participants [24%] who resided in a rural area), 583 participants (76%) completed the 4-month assessment and 523 (68%) the 12-month assessment. At 4 months, the self-directed CBT-CP was superior to clinician-delivered CBT-CP for reduction in pain interference (mean score, 5.26 vs 6.23, respectively; mean difference, -0.98; 95% CI, -1.31 to -0.65, P < .001) and maintained superiority at 6 and 12 months. Self-directed CBT-CP was superior to clinician-delivered CBT-CP for all other outcomes at 4 months (P ≤ .001). Participants in the self-directed CBT-CP group completed more expected treatment sessions than patients in the clinician-delivered CBT-CP group. CONCLUSIONS AND RELEVANCE: Self-directed CBT-CP was associated with modest improvements in pain interference at 4 months that were sustained to 12 months, small to moderate improvements in all secondary outcomes at 4 months, and higher session-completion rates, relative to clinician-delivered CBT-CP. Scalable, convenient self-directed CBT may be an effective alternative to clinician-delivered CBT that could increase uptake of CBT-CP. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03469505.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Heapy AA, Driscoll MA, Edmond S, et al. Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain: A Randomized Clinical Trial. JAMA. 2026. PMID: 42340733. doi:10.1001/jama.2026.7861

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。